• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼科皮质类固醇疗法:犬的全身效应

Ophthalmic corticosteroid therapy: systemic effects in the dog.

作者信息

Glaze M B, Crawford M A, Nachreiner R F, Casey H W, Nafe L A, Kearney M T

机构信息

Department of Veterinary Clinical Sciences, Louisiana State University, Baton Rouge 70803.

出版信息

J Am Vet Med Assoc. 1988 Jan 1;192(1):73-5.

PMID:3343186
Abstract

Degenerative myopathy suggestive of glucocorticoid-induced myopathy was diagnosed in a 10-year-old female Poodle X Pekingese dog with a history of progressive lameness. Electromyography revealed bizarre high-frequency discharges. Evidence of adrenal suppression was obtained in response to exogenous ACTH. The predominant source of corticosteroid was an ophthalmic preparation used in the management of keratoconjunctivitis sicca. Considering the apparent adverse effects of the corticosteroid in this case, a study was undertaken to determine the systemic effects, if any, induced by long-term ophthalmic administration of 0.1% dexamethasone suspension in healthy adult dogs. Dogs in one group (n = 5) were treated 4 times daily for 8 weeks, and dogs in another group (n = 5) were treated 4 times daily for 16 weeks. All dogs remained healthy throughout the study, but dexamethasone-treated dogs developed marked adrenal suppression, beginning the second week of treatment and intensifying throughout the treatment period. Histopathologic changes in the liver of dexamethasone-treated dogs included scattered foci of vacuolated hepatocytes, increased hepatocytic glycogen content, and ballooning degeneration of hepatocytes. Muscle specimens were histologically, histochemically, and electromyographically normal.

摘要

一只患有进行性跛行病史的10岁贵宾犬与北京犬杂交母犬被诊断为疑似糖皮质激素诱导性肌病的退行性肌病。肌电图显示出奇异的高频放电。对外源性促肾上腺皮质激素的反应获得了肾上腺抑制的证据。皮质类固醇的主要来源是用于治疗干眼症的眼科制剂。考虑到该病例中皮质类固醇明显的不良反应,开展了一项研究以确定在健康成年犬中长期眼部给予0.1%地塞米松混悬液是否会产生全身影响(若有)。一组犬(n = 5)每日接受4次治疗,持续8周,另一组犬(n = 5)每日接受4次治疗,持续16周。在整个研究过程中所有犬均保持健康,但地塞米松治疗的犬从治疗第二周开始出现明显的肾上腺抑制,并在整个治疗期间加重。地塞米松治疗犬肝脏的组织病理学变化包括散在的空泡化肝细胞灶、肝细胞糖原含量增加以及肝细胞气球样变性。肌肉标本在组织学、组织化学和肌电图方面均正常。

相似文献

1
Ophthalmic corticosteroid therapy: systemic effects in the dog.眼科皮质类固醇疗法:犬的全身效应
J Am Vet Med Assoc. 1988 Jan 1;192(1):73-5.
2
Atraumatic rupture of the gastrocnemius muscle after corticosteroid administration in a dog.
J Am Vet Med Assoc. 1997 Mar 1;210(5):655-7.
3
Topical administration of cyclosporine for treatment of keratoconjunctivitis sicca in dogs.局部应用环孢素治疗犬干眼症。
J Am Vet Med Assoc. 1991 Oct 15;199(8):1043-6.
4
Keratoconjunctivitis sicca and diabetes mellitus in a dog.一只狗的干眼症和糖尿病
J Am Vet Med Assoc. 1992 Jun 15;200(12):1967-8.
5
The effect of otic vehicle and concentration of dexamethasone on liver enzyme activities and adrenal function in small breed healthy dogs.耳部给药载体及地塞米松浓度对小型健康犬肝脏酶活性和肾上腺功能的影响。
Vet Dermatol. 2008 Aug;19(4):226-31. doi: 10.1111/j.1365-3164.2008.00680.x.
6
Keratoconjunctivitis sicca exacerbation in a dog treated with systemic atenolol.一只接受全身性阿替洛尔治疗的犬发生了干燥性角结膜炎加重。
J Small Anim Pract. 2016 Jul;57(7):379-81. doi: 10.1111/jsap.12477. Epub 2016 Apr 13.
7
Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.局部应用0.02%他克莫司水混悬液对干眼症犬泪液分泌的影响。
Vet Ophthalmol. 2005 Jul-Aug;8(4):225-32. doi: 10.1111/j.1463-5224.2005.00390.x.
8
Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.1%环孢素局部治疗犬干眼病的临床评估
J Am Vet Med Assoc. 1991 Oct 15;199(8):1039-42.
9
Pseudallescheria boydii keratomycosis in a dog.犬博伊德假阿利什菌性角膜溃疡
J Am Vet Med Assoc. 1992 Jan 15;200(2):199-202.
10
A retrospective study of probable glucocorticoid-induced hepatopathy in dogs.
J Am Vet Med Assoc. 1977 Mar 15;170(6):603-6.

引用本文的文献

1
Development of Crystalline Corneal Opacities (Steroid Keratopathy) in Dogs After Treatment With Ophthalmic Corticosteroids.犬使用眼科皮质类固醇治疗后结晶性角膜混浊(类固醇性角膜病)的发生情况
Cornea. 2024 Dec 1;43(12):1506-1515. doi: 10.1097/ICO.0000000000003523. Epub 2024 Mar 13.
2
Systemic Treatment of Immune-Mediated Keratoconjunctivitis Sicca with Allogeneic Stem Cells Improves the Schirmer Tear Test Score in a Canine Spontaneous Model of Disease.同种异体干细胞对免疫介导的干燥性角结膜炎进行全身治疗可提高犬自发性疾病模型的泪液分泌试验评分。
J Clin Med. 2021 Dec 20;10(24):5981. doi: 10.3390/jcm10245981.
3
Localized alopecia and suppression of hypothalamic-pituitary-adrenal (HPA) axis in dogs following treatment with difluprednate 0.05% ophthalmic emulsion (Durezol®).
局部脱发和犬用二氟泼尼龙 0.05%眼用乳剂(Durezol®)治疗后的下丘脑-垂体-肾上腺(HPA)轴抑制。
BMC Vet Res. 2021 Dec 1;17(1):366. doi: 10.1186/s12917-021-03072-9.
4
Tear Film Pharmacokinetics and Systemic Absorption Following Topical Administration of 1% Prednisolone Acetate Ophthalmic Suspension in Dogs.1%醋酸泼尼松龙滴眼液眼部给药后犬泪膜的药代动力学及全身吸收情况
Front Vet Sci. 2020 Oct 27;7:571350. doi: 10.3389/fvets.2020.571350. eCollection 2020.